Cardiology Headline News

ATLANTA — For patients with nonobstructive hypertrophic cardiomyopathy, ninerafaxstat, a novel cardiac mitotrope, safely improved HF symptoms during a 12-week period vs. placebo, a speaker reported.

Black adolescents who face more racial discrimination may be more likely to have metabolic syndrome at age 31 years, according to findings published in JAMA Network Open.

More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.

Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia.

ATLANTA — A home-based exercise intervention with protein supplementation improved physical performance at 12 weeks for older patients with frailty who underwent transcatheter aortic valve replacement, according to the PERFORM-TAVR trial.

Researchers have discovered the mechanisms by which the chemotherapy drug ponatinib harms the heart.

Researchers found a U-shaped association between alcohol consumption and risk for peripheral artery disease, with the lowest risk seen with consuming two drinks per week and more pronounced risk with at least 10 drinks, study data showed.

In a meta-analysis of studies covering more than 400,000 people, climbing stairs was associated with reduced risk for all-cause mortality and death from heart disease.

Progress has been made in the creation of a new independent Board of Cardiovascular Medicine under the American Board of Medical Specialties, several cardiology societies announced.

Air pollution accentuates the relationship between poor mental health and premature mortality from heart disease in the United States, researchers reported at ESC Preventive Cardiology 2024.